hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Cortisporin]

RxCUI
206511
RxNorm name
hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Cortisporin]
Display name
CORTISPORIN (Otic)
Full name
hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Cortisporin]
Term type
SBD
Status
Active
Strength
10-3.5-10,000 var units
Dose form
Sol
Route
Otic
Updated
2026-11-19 15:43:47

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
hydrocortisone10 MG / 1 MLhydrocortisonehydrocortisone
neomycin sulfate3.5 MG / 1 MLneomycinneomycin
polymyxin B sulfate10000 UNT / 1 MLpolymyxin Bpolymyxin B

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Otic Solution316973

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
hydrocortisone5492
neomycin7299
polymyxin B8536

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 14 matching rows.

NDC11, Source, Active table
NDC11SourceActive
61570003410rxnav_ndcsyes
00081019992rxnav_historical
00173019992rxnav_historical
16590006210rxnav_historical
35356051710rxnav_historical
52959116000rxnav_historical
54569089000rxnav_historical
54868021301rxnav_historical
55887076575rxnav_historical
58016601700rxnav_historical
63552019810rxnav_historical
63552019892rxnav_historical
63552019910rxnav_historical
63552019992rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
ea918e98-cb19-4422-9a7e-1a94aafc850fNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01AAAntibioticsATC1-4polymyxin B
ATCA07AAAntibioticsATC1-4polymyxin B
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCA07AAAntibioticsATC1-4neomycin
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCB05CAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4polymyxin B
ATCS03AAAntiinfectivesATC1-4polymyxin B
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCC05AACorticosteroidsATC1-4hydrocortisone
ATCS02BACorticosteroidsATC1-4hydrocortisone
ATCA07EACorticosteroids acting locallyATC1-4hydrocortisone
ATCA01ACCorticosteroids for local oral treatmentATC1-4hydrocortisone
ATCS01BACorticosteroids, plainATC1-4hydrocortisone
ATCD07AACorticosteroids, weak (group I)ATC1-4hydrocortisone
ATCD07XACorticosteroids, weak, other combinationsATC1-4hydrocortisone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4hydrocortisone
ATCH02ABGlucocorticoidsATC1-4hydrocortisone
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
ATCJ01XBPolymyxinsATC1-4polymyxin B
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175576CorticosteroidEPChas_epchydrocortisone
FDASPLN0000175499Polymyxin-class AntibacterialEPChas_epcpolymyxin B
MEDRTD006854HydrocortisoneCHEMhas_ingredienthydrocortisone
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD011112Polymyxin BCHEMhas_ingredientpolymyxin B
MEDRTD000312Adrenal Hyperplasia, CongenitalDISEASEmay_treathydrocortisone
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treathydrocortisone
MEDRTD016470BacteremiaDISEASEmay_treatpolymyxin B
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD003093Colitis, UlcerativeDISEASEmay_treathydrocortisone
MEDRTD003877Dermatitis, ContactDISEASEmay_treathydrocortisone
MEDRTD003881DermatomycosesDISEASEci_withhydrocortisone
MEDRTD004342Drug HypersensitivityDISEASEci_withpolymyxin B
MEDRTD004342Drug HypersensitivityDISEASEci_withhydrocortisone
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatpolymyxin B
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatpolymyxin B
MEDRTD005148Facial DermatosesDISEASEmay_treathydrocortisone
MEDRTD005533Foot DermatosesDISEASEmay_treathydrocortisone
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatpolymyxin B
MEDRTD006192Haemophilus InfectionsDISEASEmay_treatpolymyxin B
MEDRTD006229Hand DermatosesDISEASEmay_treathydrocortisone
MEDRTD006484HemorrhoidsDISEASEmay_treathydrocortisone
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD007249InflammationDISEASEmay_treathydrocortisone
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD007710Klebsiella InfectionsDISEASEmay_treatpolymyxin B
MEDRTD007868Leg DermatosesDISEASEmay_treathydrocortisone
MEDRTD016920Meningitis, BacterialDISEASEmay_treatpolymyxin B
MEDRTD010032Otitis ExternaDISEASEmay_treatpolymyxin B
MEDRTD011538Pruritus AniDISEASEmay_treathydrocortisone
MEDRTD011552Pseudomonas InfectionsDISEASEmay_treatpolymyxin B
MEDRTD012216Rheumatic DiseasesDISEASEmay_treathydrocortisone
MEDRTD012536Scalp DermatosesDISEASEmay_treathydrocortisone
MEDRTD012769ShockDISEASEmay_treathydrocortisone
MEDRTD012871Skin DiseasesDISEASEmay_treatpolymyxin B
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTD012876Skin Diseases, ParasiticDISEASEci_withhydrocortisone
MEDRTD017193Skin Diseases, ViralDISEASEci_withhydrocortisone
MEDRTD018461Soft Tissue InfectionsDISEASEmay_treatpolymyxin B
MEDRTD013224Status AsthmaticusDISEASEmay_treathydrocortisone
MEDRTD014382Tuberculosis, CutaneousDISEASEci_withhydrocortisone
MEDRTD001745Urinary Bladder DiseasesDISEASEmay_treatpolymyxin B
MEDRTD014947Wounds and InjuriesDISEASEmay_treatpolymyxin B
MEDRTN0000000226Acid-Base ActivityMOAhas_moapolymyxin B
MEDRTN0000000227Cholinergic Nicotinic AntagonistsMOAci_moapolymyxin B
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moahydrocortisone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moahydrocortisone
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pehydrocortisone
MEDRTN0000008346Cellular Structure AlterationPEhas_pepolymyxin B
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pehydrocortisone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pehydrocortisone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pehydrocortisone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pehydrocortisone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pehydrocortisone
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pehydrocortisone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pehydrocortisone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pehydrocortisone
MEDRTN0000008841Decreased Protein SynthesisPEhas_peneomycin
MEDRTN0000008953Decreased Striated Muscle ContractionPEci_pepolymyxin B
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pehydrocortisone
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pehydrocortisone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG/ML / 3.5 MG/ML / 10000 UNT/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymCORTISPORIN 0.35 % / 10,000 UNT/ML / 1 % Otic Solution
SOURCESSourceGold Standard Alchemy